Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer

PURPOSE: Carboplatin is a first-line treatment for ovarian cancer. However, most patients develop resistance and undergo disease recurrence. This study aims to explore the relationship between the expression of X-linked inhibitor of apoptosis protein (XIAP) and carboplatin sensitivity in ovarian can...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yiping, Huang, Furong, Luo, Qingyu, Wu, Xiaowei, Liu, Zhihua, Chen, Hongyan, Huang, Yinghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287417/
https://www.ncbi.nlm.nih.gov/pubmed/30584333
http://dx.doi.org/10.2147/OTT.S171053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287417/
https://www.ncbi.nlm.nih.gov/pubmed/30584333
http://dx.doi.org/10.2147/OTT.S171053

Ejemplares similares